JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;134:1419-1420
© 2007 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Discussion

The first 20% of the full text of this article appears below.

Mr Cliff K. Choong (Cambridge, United Kingdom). Congratulations on your very good study and results. Based on this, have you changed your practice to use this device for all your subsequent patients?

Dr Corno. First of all, we now can use this device in any patient because the hospital administration is convinced that, despite the initial cost, we can spare the money.

Regarding the management, we changed a lot of policies. For instance, patients with multiple ventricular septal defects are now, in the neonatal period, treated with this device. Now we have a group of 5 patients, on average 2 to 3 years after surgical intervention, and we follow all of them. Of course, when the patient grows and the body weight increases, we can release the device to avoid the right ventricular pressure becoming suprasystemic. And in 4 patients all multiple ventricular septal defects, 21/2 to 3 years after surgical intervention, underwent spontaneous closure. Two weeks ago, I operated on one patient, removing the device, and without anything else required, even the pulmonary artery reconstruction was not necessary. Much easier is the management, of course, of a univentricular heart, for obvious reasons, because you can titrate the distal pulmonary artery pressure as you want based on echocardiographic results. In the group for left ventricular retraining, we have only 4 patients, but the number is increasing and, . . . [Full Text of this Article]


Related Article

FloWatch versus conventional pulmonary artery banding
Antonio F. Corno, Edmund J. Ladusans, Marco Pozzi, and Stephen Kerr
J. Thorac. Cardiovasc. Surg. 2007 134: 1413-1420. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.